Skip to search formSkip to main contentSkip to account menu

loxiglumide

Known as: (+-)-4-((3,4-Dichlorobenzoyl)amino)-5-((3-methoxypropyl)pentylamino)-5-oxopentanoic Acid, 4-(3,4-dichlorobenzoylamino)-5-(N-3-methoxypropylpentylamino)-5-oxopentanoic acid, D,L-4-(3,4-Dichlorobenzoylamino)-5-(N-3-methoxypropylpentylamino)-5-oxo-pentanoic Acid 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (1)

CR 1505

Broader (2)

Hormone AntagonistsProglumide
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2002
Review
2002
Transient lower oesophageal sphincter relaxations—a pharmacological target for gastro‐oesophageal reflux disease?
The oesophago‐gastric junction functions as an anti‐reflux barrier preventing increased exposure of the oesophageal mucosa to… 
1998
1998
Long-Term Effects of CCK-Agonist and -Antagonist on Food Intake and Body Weight in Zucker Lean and Obese Rats
1997
1997
CCK-resistance in Zucker obese versus lean rats
Highly Cited
1995
Highly Cited
1995
Role of endogenous gastrin in gastroprotection.
1994
1994
Cholecystokinin is a negative regulator of gastric acid secretion and postprandial release of gastrin in humans.
1992
1992
A physiological role for cholecystokinin as a regulator of gastrin secretion.
Highly Cited
1991
Highly Cited
1991
Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide.
To evaluate the physiological role of cholecystokinin (CCK) in humans, we studied the influence of the specific CCK receptor… 
1991
1991
Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro‐entero‐pancreatic hormones in man Feedback control of cholecystokinin and gastrin secretion
Abstract. The effect of the potent specific cholecystokinin (CCK) receptor antagonist loxiglumide on meal‐stimulated plasma… 
Highly Cited
1989
Highly Cited
1989
Differential effects of atropine and a cholecystokinin receptor antagonist on pancreatic secretion.
1987
1987
Anticholecystokinin activities of loxiglumide.
The anticholecystokinin activities of loxiglumide, (D,L-4-(3,4-dichloro-benzoylamino)-5-(N-3-methoxypropyl-pentylamino++ +)-5-oxo… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)